v3.26.3
CONDENSED CONSOLIDATED STATEMENTS OF CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' EQUITYS (DEFICIT) - USD ($)
Series A Convertible Preferred Stock
Preferred Stock
Common Stock
Additional Paid-in-Capital
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Total
Beginning Balance at Dec. 31, 2023         $ (178) $ (178)
Issuance of common stock on vesting of restricted stock units, Shares   558,511        
Issuance of common stock on vesting of restricted stock units   $ 6 $ (6)      
Foreign currency translation adjustments       $ (609)   (609)
Net loss         (2,069,642) (2,069,642)
Ending Balance, Shares at Dec. 31, 2024   558,511        
Ending Balance at Dec. 31, 2024   $ 6 1,207 (609) (2,069,820) (2,069,216)
Issuance of common stock on vesting of restricted stock units, Shares   176,372        
Issuance of common stock on vesting of restricted stock units   $ 2 (2)      
Share-based compensation     28,488     28,488
Foreign currency translation adjustments       14,744   14,744
Net loss         (2,321,159) (2,321,159)
Ending Balance, Shares at Jun. 30, 2025   734,883        
Ending Balance at Jun. 30, 2025   $ 8 29,693 14,135 (4,390,979) (4,347,143)
Beginning Balance, Shares at Dec. 31, 2024   558,511        
Beginning Balance at Dec. 31, 2024   $ 6 1,207 (609) (2,069,820) (2,069,216)
Issuance of common stock on vesting of restricted stock units, Shares   352,744        
Issuance of common stock on vesting of restricted stock units   $ 4 (4)      
Share-based compensation     194,743     194,743
Foreign currency translation adjustments       (4,291)   (4,291)
Net loss         (8,529,263) $ (8,529,263)
Ending Balance, Shares at Dec. 31, 2025 3,661,083         3,661,083
Ending Balance at Dec. 31, 2025 $ 19,013,673         $ 19,013,673
Ending Balance, Shares at Dec. 31, 2025   911,255        
Ending Balance at Dec. 31, 2025   $ 10 663,514 (4,900) (10,599,083) (9,940,459)
Beginning Balance, Shares at Mar. 31, 2025   646,697        
Beginning Balance at Mar. 31, 2025   $ 7 11,439 (343) (2,763,797) (2,752,694)
Issuance of common stock on vesting of restricted stock units, Shares   88,186        
Issuance of common stock on vesting of restricted stock units   $ 1 (1)      
Share-based compensation     18,255     18,255
Foreign currency translation adjustments       14,478   14,478
Net loss         (1,627,182) (1,627,182)
Ending Balance, Shares at Jun. 30, 2025   734,883        
Ending Balance at Jun. 30, 2025   $ 8 29,693 14,135 (4,390,979) (4,347,143)
Beginning Balance, Shares at Dec. 31, 2025   911,255        
Beginning Balance at Dec. 31, 2025   $ 10 663,514 (4,900) (10,599,083) (9,940,459)
Sale of Series A-1 convertible preferred stock, Shares 558,116          
Sale of Series A-1 convertible preferred stock $ 3,472,095 $ 0 0 0 0 0
Issuance of common stock and pre-funded warrants for conversion of Series A convertible preferred stock,Shares (4,219,199) 6,137,634        
Issuance of common stock and pre-funded warrants for conversion of Series A convertible preferred stock $ (22,485,768) $ 61 22,485,707     22,485,768
Issuance of common stock under initial public offering, net of underwriters discounts, Shares   3,450,000        
Issuance of common stock under initial public offering, net of underwriters discounts   $ 35 16,014,965     16,015,000
Issuance of shares under ELOC, Shares   313,996        
Issuance of shares under ELOC   $ 3 13,778,097     13,778,100
Reclassification of deferred financing costs to additional paid-in capital upon consummation of public offering and sale of Series A convertible preferred stock     (1,004,333)     $ (1,004,333)
Issuance of common stock upon exercise of stock options, Shares   211,647       211,647
Issuance of common stock upon exercise of stock options   $ 2 (2)      
Issuance of common stock on vesting of restricted stock units, Shares   260,237        
Issuance of common stock on vesting of restricted stock units   $ 2 (2)      
Share-based compensation     1,459,980     $ 1,459,980
Foreign currency translation adjustments       200,402   200,402
Net loss         (11,783,873) $ (11,783,873)
Ending Balance, Shares at Jun. 30, 2026 0         0
Ending Balance at Jun. 30, 2026 $ 0          
Ending Balance, Shares at Jun. 30, 2026   11,284,769        
Ending Balance at Jun. 30, 2026   $ 113 53,397,926 195,502 (22,382,956) $ 31,210,585
Beginning Balance, Shares at Mar. 31, 2026   10,798,722        
Beginning Balance at Mar. 31, 2026   $ 110 38,606,840 (28,441) (15,057,918) 23,520,591
Issuance of shares under ELOC, Shares   313,996        
Issuance of shares under ELOC   $ 3 13,778,097     13,778,100
Reclassification of deferred financing costs to additional paid-in capital upon consummation of public offering and sale of Series A convertible preferred stock     (165,111)     (165,111)
Issuance of common stock on vesting of restricted stock units, Shares   172,051        
Share-based compensation     1,178,100     1,178,100
Foreign currency translation adjustments       223,943   223,943
Net loss         (7,325,038) $ (7,325,038)
Ending Balance, Shares at Jun. 30, 2026 0         0
Ending Balance at Jun. 30, 2026 $ 0          
Ending Balance, Shares at Jun. 30, 2026   11,284,769        
Ending Balance at Jun. 30, 2026   $ 113 $ 53,397,926 $ 195,502 $ (22,382,956) $ 31,210,585